EU Lawmakers Seal Overhaul of Pharmaceutical Rulebook

Mace | 12th December 2025 | Brussels, International, Lobbying
Pharmacie_in_Paulista_Avenue

European legislators agree major reforms to medicines law, reshaping market exclusivity, boosting access, and tightening rules on shortages and antibiotics

European Union legislators have clinched an agreement on a sweeping overhaul of the bloc’s pharmaceutical policies after more than two years of negotiations involving the European Commission, the European Parliament and the Council of the European Union. The political agreement reached in early December represents the first significant revision of EU medicines law in over two decades and covers a comprehensive set of changes to how medicines are regulated, made available and supported across member states. The package is intended to increase access to medicines in the EU by modernising regulatory frameworks that had remained substantially unchanged for around twenty years. Under the provisional terms agreed by legislators, the reform will change rules on market exclusivity and regulatory data protection for new medicines, introduce measures to strengthen supply chains, and revise how shortages are monitored and managed across the Union. One of the central elements of the package involv...

Subscribe to The Mace

Join the member community shaping British politics and stay ahead of what's really happening in the world of politics and public affairs, with expert analysis, breaking news, and insider insights from Westminster and Brussels. The Mace is the leading news source and resource for the government affairs industry, offering required reading and lobby intelligence for professionals.

To see what you are missing out on by not subscribing to The Mace, click here to download our full membership info-pack. This includes having no paywall on op-ed content or profiles/interviews, allowing professional profiles to be read with maximum impact and visibility by government, special advisers, MPs, peers, civil servants, and policy and political decision-makers.



See no evil: Brussels’ selective blindness in the race for Europe’s east

Mace | November 19, 2026

In its contest with Moscow for Europe’s eastern edge, the EU has started overlooking how prospective members govern. From the Balkans to the Caucasus, it is proving a costly miscalculation.

Leader in Public Affairs: Tristan Breijer, Senior Advisor UK and EU, Checkmate Government Relations – “Transparency is good for the profession”

Mace | November 18, 2026

Breijer is Senior Advisor UK and EU at Checkmate Government Relations, the Washington DC lobbying firm

‘A watershed moment’: The lobbyists behind the Milburn Review

Lucy Carrier-Pilkington | November 18, 2026

Alan Milburn’s review into the youth unemployment crisis has been called ‘absurdly ambitious’ as it does not just address the issues faced by NEETs, but also businesses, schools

Into overdrive: AI lobbying of ministers up eleven-fold since 2022

Lucy Carrier-Pilkington | November 17, 2026

A worrying trend has emerged in the UK and the US, with AI-related lobbying growing at an exponential rate.

Britain’s £113 Million Investment in Ukrainian Drones: A New Chapter in Defence Cooperation?

Anna Bryzhko | November 17, 2026

Moving past traditional military aid, the UK is putting money into Ukraine’s battlefield-tested technology, aiming to grow both countries' defence industries and strengthen their alliance.

CHOGM Antigua Diary: all the instruments, little real music

Mace Magazine | November 8, 2026

After CHOGM in Antigua, the Commonwealth has plainly endured. The question is whether it can thrive, asks Tristan Breijer

The ex-Cameron outsider who ran out of road in California

William Cash | November 4, 2026

Steve Hilton, David Cameron's one-time guru, has lost his bid to become California's first Republican governor in 20 years. So where does a man of so many reinventions

Donald, the lame duck: Trump after the midterms

William Cash | November 4, 2026

Trump told America to treat the midterms as a vote on him. It did. Now comes the reckoning, writes Mace editor-in-chief William Cash from California.

Blue Tsunami on K Street: Lobbyists Face a Democratic Congress

Mace Magazine | November 4, 2026

With the Democrats sweeping to victory in the midterms, it looks like many US lobbying firms may have made the wrong bet. Over the next two years, K

The midterms: what next for President Trump?

Mace Magazine | November 3, 2026

Voters look set to hand the president a drubbing in today's vote across the USA. The harder question is what he does with the two years that remain,